下垂足治療デバイス：市場洞察・競合環境・市場予測 (～2030年)

下垂足治療デバイスの市場規模は、2024年から2030年までの予測期間中にCAGR 8.15％で成長すると予測されています。

下垂足治療デバイスの市場は、多発性硬化症を含む慢性神経疾患の有病率の上昇、下肢痛の症例数の増加、老齢人口の増加などの要因から、大幅な市場成長を示しています。

下垂足治療デバイス：市場力学

WHOのデータ (2023年) によると、世界で180万人以上が多発性硬化症に罹患していると報告されています。この疾患は認知、感情、運動、感覚、視覚能力を含む様々な機能に影響を及ぼします。多発性硬化症は、免疫系が誤って脳や脊髄を攻撃することで発症します。多発性硬化症は、しばしば下垂足を含む運動障害を引き起こすため、多発性硬化症の増加は下垂足治療デバイスの需要を大きく牽引しています。多発性硬化症は運動機能と自立性を阻害するため、歩行を回復させる機能的電気刺激装置のような高度なソリューションが必要となります。

WHOが2021年に発表したデータによると、2015年から2050年の間に、転倒事故の60歳以上の割合は12％から22％に倍増し、2050年には世界全体で21億人に達すると報告されています。さらに2030年には、6人に1人が60歳以上の高齢者となります。世界人口の高齢化は、脳卒中、末梢神経障害、変性疾患のような加齢関連疾患の有病率を増加させますが、これらは下垂足の主な原因となっています。このため、高齢者の運動能力を高め、生活の質を向上させるための治療デバイスに対する需要が高まっています。

製品タイプ別では、電気刺激装置の部門が2023年に大きな収益シェアを示しています。これは、非侵襲的な性質、機能的な動きを回復させる能力、筋肉の再教育における有効性に起因しています。

これらの機器は、高度な機能的電気刺激技術を用いて背屈筋を活性化し、歩行を改善して転倒のリスクを軽減します。携帯性、カスタマイズオプション、ウェアラブルデザインにより、日常的な使用に便利です。また、脳卒中や多発性硬化症などの神経疾患に対するリハビリテーションへの応用や治療効果に対する認識が高まっていることも、この製品の普及を後押ししています。

当レポートでは、世界の下垂足治療デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 下垂足治療デバイス市場レポート：イントロダクション

• 調査範囲
• 市場の分類
• 市場の想定

第2章 下垂足治療デバイス市場：エグゼクティブサマリー

• 市場概要

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 下垂足治療デバイス市場：主要要因分析

• 市場促進要因
  • 慢性神経疾患の有病率の上昇
  • 下肢疼痛の増加
  • 高齢化人口の増加
• 市場抑制要因と課題
  • 長期使用に伴う副作用
  • フィッティング関連の問題
• 市場機会
  • パーソナライズされたウェアラブルソリューションの開発

第6章 下垂足治療デバイス市場：ポーターのファイブフォース分析

第7章 下垂足治療デバイス市場の評価

• 製品タイプ別
  • 電気刺激装置
  • 装具/副木
• 用途別
  • 神経障害
  • 筋肉障害
  • 脳と脊髄の疾患
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 下垂足治療デバイス市場：企業・製品プロファイル

• Ottobock
• Bioness Inc
• AxioBionics
• Saebo, Inc.
• OrthoPediatrics Corp.
• Turbomed Orthotics
• Ossur
• Thrive Orthopedics
• Allard USA Inc.
• NextStep Robotics
• Arthrex, Inc.
• Evolution Devices
• Narang Medical Limited
• AliMed
• Cionic

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Foot Drop Treatment Devices Market in Global (2021-2030)
• Table 3: Foot Drop Treatment Devices Market in Global by Product Type (2021-2030)
• Table 4: Foot Drop Treatment Devices Market in Global by Application (2021-2030)
• Table 5: Foot Drop Treatment Devices Market in Global by Geography (2021-2030)
• Table 6: Foot Drop Treatment Devices Market in North America (2021-2030)
• Table 7: Foot Drop Treatment Devices Market in the United States (2021-2030)
• Table 8: Foot Drop Treatment Devices Market in Canada (2021-2030)
• Table 9: Foot Drop Treatment Devices Market in Mexico (2021-2030)
• Table 10: Foot Drop Treatment Devices Market in Europe (2021-2030)
• Table 11: Foot Drop Treatment Devices Market in France (2021-2030)
• Table 12: Foot Drop Treatment Devices Market in Germany (2021-2030)
• Table 13: Foot Drop Treatment Devices Market in United Kingdom (2021-2030)
• Table 14: Foot Drop Treatment Devices Market in Italy (2021-2030)
• Table 15: Foot Drop Treatment Devices Market in Spain (2021-2030)
• Table 16: Foot Drop Treatment Devices Market in the Rest of Europe (2021-2030)
• Table 17: Foot Drop Treatment Devices Market in Asia-Pacific (2021-2030)
• Table 18: Foot Drop Treatment Devices Market in China (2021-2030)
• Table 19: Foot Drop Treatment Devices Market in Japan (2021-2030)
• Table 20: Foot Drop Treatment Devices Market in India (2021-2030)
• Table 21: Foot Drop Treatment Devices Market in Australia (2021-2030)
• Table 22: Foot Drop Treatment Devices Market in South Korea (2021-2030)
• Table 23: Foot Drop Treatment Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Foot Drop Treatment Devices Market in the Rest of the World (2021-2030)
• Table 25: Foot Drop Treatment Devices Market in the Middle East (2021-2030)
• Table 26: Foot Drop Treatment Devices Market in Africa (2021-2030)
• Table 27: Foot Drop Treatment Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Foot Drop Treatment Devices Market in Global (2021-2030)
• Figure 3: Foot Drop Treatment Devices Market in Global by Product Type (2021-2030)
• Figure 4: Foot Drop Treatment Devices Market in Global by Application (2021-2030)
• Figure 5: Foot Drop Treatment Devices Market in Global by Geography (2021-2030)
• Figure 6: Foot Drop Treatment Devices Market in North America (2021-2030)
• Figure 7: Foot Drop Treatment Devices Market in the United States (2021-2030)
• Figure 8: Foot Drop Treatment Devices Market in Canada (2021-2030)
• Figure 9: Foot Drop Treatment Devices Market in Mexico (2021-2030)
• Figure 10: Foot Drop Treatment Devices Market in Europe (2021-2030)
• Figure 11: Foot Drop Treatment Devices Market in France (2021-2030)
• Figure 12: Foot Drop Treatment Devices Market in Germany (2021-2030)
• Figure 13: Foot Drop Treatment Devices Market in United Kingdom (2021-2030)
• Figure 14: Foot Drop Treatment Devices Market in Italy (2021-2030)
• Figure 15: Foot Drop Treatment Devices Market in Spain (2021-2030)
• Figure 16: Foot Drop Treatment Devices Market in the Rest of Europe (2021-2030)
• Figure 17: Foot Drop Treatment Devices Market in Asia-Pacific (2021-2030)
• Figure 18: Foot Drop Treatment Devices Market in China (2021-2030)
• Figure 19: Foot Drop Treatment Devices Market in Japan (2021-2030)
• Figure 20: Foot Drop Treatment Devices Market in India (2021-2030)
• Figure 21: Foot Drop Treatment Devices Market in Australia (2021-2030)
• Figure 22: Foot Drop Treatment Devices Market in South Korea (2021-2030)
• Figure 23: Foot Drop Treatment Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Foot Drop Treatment Devices Market in the Rest of the World (2021-2030)
• Figure 25: Foot Drop Treatment Devices Market in the Middle East (2021-2030)
• Figure 26: Foot Drop Treatment Devices Market in Africa (2021-2030)
• Figure 27: Foot Drop Treatment Devices Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Marker Opportunities
• Figure 31: PORTER'S Five Force Analysis

Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2030 owing to the rising prevalence of chronic neurological disorders and the growing cases of lower limb pain worldwide

The foot drop treatment devices market is projected to grow at a CAGR of 8.15% during the forecast period from 2024 to 2030. The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.

Foot Drop Treatment Devices Market Dynamics:

As per data from the World Health Organization (WHO) (2023), it was reported that over 1.8 million people worldwide are affected by multiple sclerosis. It impacts various functions including cognitive, emotional, motor, sensory, and visual abilities. It occurs when the immune system mistakenly attacks the brain and the spinal cord. The prevalence of multiple sclerosis significantly drives the demand for foot drop treatment devices, as multiple sclerosis often leads to motor impairments, including foot drop. The condition disrupts mobility and independence, requiring advanced solutions like functional electrical stimulators to restore gait.

As per data provided by the WHO 2021, between 2015 and 2050, people falling between 60 years and above will be doubled from 12 to 22%, and will eventually reach 2.1 billion by 2050, globally. Moreover, by 2030, 1 in 6 people will age 60 years or above. The aging global population increases the prevalence of age-related conditions like stroke, peripheral neuropathy, and degenerative disorders, which are major causes of foot drop. This drives the demand for treatment devices to enhance mobility and improve the quality of life in elderly individuals.

Therefore, all the factors stated above collectively will drive the overall foot drop treatment devices market growth.

However, the side effects associated with prolonged usage, fitting-related issues, and others may prove to be challenging factors for the foot drop treatment devices market growth during the forecast period.

Foot Drop Treatment Devices Market Segment Analysis:

Foot Drop Treatment Devices Market by Product Type (Electrical Stimulator and Braces/Splints), Application (Neuropathy, Muscle Disorders, Brain & Spinal Disorders, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the foot drop treatment devices, the electrical stimulator category is expected to have a significant revenue share in the year 2023. This is due to their non-invasive nature, ability to restore functional movement, and effectiveness in re-educating muscles.

These devices use advanced functional electrical stimulation technology to activate dorsiflexor muscles, improving gait and reducing the risk of falls. Their portability, customization options, and compatibility with wearable designs make them convenient for daily use. Additionally, the increasing awareness about their therapeutic benefits and their application in rehabilitation for neurological conditions like stroke and multiple sclerosis is further expected to drive their adoption.

Therefore, the widespread uses and key features of electrical stimulators that enhance their performance are solidifying the impact on the growth of the overall foot drop treatment devices market, during the forecast period from 2024 to 2030.

North America is expected to dominate the overall foot drop treatment devices market:

Among all the regions, North America is expected to dominate the foot drop treatment devices market in the year 2023 and is expected to do the same during the forecast period. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.

According to data from the Centers of Disease Control and Prevention (2023), it was stated that guillain-barre syndrome is a rare disorder in which the body's immune system mistakenly attacks the peripheral nerves. This damage to the nerves leads to muscle weakness and, in some cases, paralysis. In the United States, an estimated 3,000 to 6,000 people develop guillain-barre syndrome each year. Thus the rising cases of guillain-barre syndrome is increasing demand for foot drop treatment devices as guillain-barre syndrome often causes nerve damage leading to muscle weakness and foot drop.

Further, the Centre for Disease Control and Prevention (2021), stated that the percentage of adults experiencing lower limb pain rose with age, starting at 21.0% for individuals aged 18-29, increasing to 28.8% for those aged 30-44, 43.4% for adults aged 45-64, and reaching 50.3% for those aged 65 and over. The increasing prevalence of lower limb pain with age is driving the demand for foot drop treatment devices. As more individuals experience knee issues or age-related pain, the likelihood of developing foot drop increases, creating a larger patient base for assistive devices to improve mobility and quality of life.

Additionally, the prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional foot drop treatment devices market growth. The presence of key players with their strong distribution networks ensures widespread availability and accessibility of these devices across the region, thus increasing their revenue shares in the market, along with supportive reimbursement programs providing immense growth opportunities for the same.

Therefore, the interplay of all the aforementioned factors would provide a conducive growth environment for the North American foot drop treatment devices market.

Foot Drop Treatment Devices Market key players:

Some of the key market players operating in the foot drop treatment devices market include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.

Recent Developmental Activities in the Foot Drop Treatment Devices Market:

• In March 2022, Cionic, a company committed to improving the lives of people with mobility differences by helping them move more independently through bionic clothing, announced the FDA clearance for its lightweight leg-worn Cionic Neural Sleeve(TM), a functional electrical stimulation to assist in gait for people with foot drop and leg muscle weakness.
• In September 2021, Evolution Devices announced the launch of its EvoWalk Platform pilot program to rehabilitate walking for people living with neurologically-based partial walking paralysis. EvoWalk remote therapy platform allows foot drop patients to meet with physical therapists (PTs) virtually, providing them with a personalized and comprehensive rehab program to help them improve their mobility.

Key Takeaways from the Foot Drop Treatment Devices Market Report Study

• Market size analysis for current foot drop treatment devices market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the foot drop treatment devices market.
• Various opportunities available for the other competitors in the foot drop treatment devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current foot drop treatment devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for foot drop treatment devices market growth in the coming future?

Target Audience who can be benefited from this Foot Drop Treatment Devices Market Report Study

• Foot drop treatment devices product providers
• Research organizations and consulting companies
• Foot drop treatment devices-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in foot drop treatment devices
• Various end-users who want to know more about the foot drop treatment devices market and the latest technological developments in the foot drop treatment devices market.

Frequently Asked Questions for the Foot Drop Treatment Devices Market:

1. What are foot drop treatment devices?

• A foot drop treatment device is a medical device designed to assist individuals with foot drop, a condition characterized by difficulty in lifting the front part of the foot due to weakness or paralysis of the dorsiflexor muscles.

2. What is the market for foot drop treatment devices?

• The foot drop treatment devices market is projected to grow at a rate of 8.15% CAGR during the forecast period forecast period from 2024 to 2030.

3. What are the drivers for the foot drop treatment devices market?

• The foot drop treatment devices market is observing substantial market growth primarily owing to the rising prevalence of chronic neurological disorders including multiple sclerosis, growing cases of lower limb pain, and the rising geriatric population that are expected to escalate the overall growth of the foot drop treatment devices market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the foot drop treatment devices market?

• Some of the key market players operating in foot drop treatment devices include Ottobock, Bioness Inc, AxioBionics, Saebo, Inc., OrthoPediatrics Corp., Turbomed Orthotics, Ossur, Thrive Orthopedics, Allard USA Inc., NextStep Robotics, Arthrex, Inc., Evolution Devices, Narang Medical Limited, AliMed, Cionic, and others.

5. Which region has the highest share in the foot drop treatment devices market?

• North America is expected to dominate the overall Foot Drop Treatment Devices market during the forecast period from 2024 to 2030. This can be attributed to several factors including the high instances of guillain-barre syndrome, increasing cases of lower limb pain combined with significant advancements in product development & regulatory approvals, the presence of market key players, and the availability of well-established advanced healthcare infrastructure; acting as key factors contributing to the growth of the foot drop treatment devices market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Foot Drop Treatment Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Foot Drop Treatment Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Foot Drop Treatment Devices Market Key Factors Analysis

• 5.1. Foot Drop Treatment Devices Market Drivers
  • 5.1.1. Rising prevalence of chronic neurological disorders
  • 5.1.2. Growing cases of lower limb pain
  • 5.1.3. Rising geriatric population
• 5.2. Foot Drop Treatment Devices Market Restraints and Challenges
  • 5.2.1. Side effects associated with prolonged usage
  • 5.2.2. Fitting-related issues
• 5.3. Foot Drop Treatment Devices Market Opportunities
  • 5.3.1. Development of personalized wearable solutions

6. Foot Drop Treatment Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Foot Drop Treatment Devices Market Assessment

• 7.1. By Product Type
  • 7.1.1. Electrical Stimulator
  • 7.1.2. Braces/Splints
• 7.2. By Application
  • 7.2.1. Neuropathy
  • 7.2.2. Muscle Disorders
  • 7.2.3. Brain & Spinal Disorders
  • 7.2.4. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.1.2. Canada Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.1.3. Mexico Foot Drop Treatment Devices Market Size in USD million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.2.2. Germany Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.2.3. United Kingdom Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.2.4. Italy Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.2.5. Spain Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.2.6. Rest of Europe Foot Drop Treatment Devices Market Size in USD million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.3.2. Japan Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.3.3. India Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.3.4. Australia Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.3.5. South Korea Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Foot Drop Treatment Devices Market Size in USD million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.4.2. Africa Foot Drop Treatment Devices Market Size in USD million (2021-2030)
    • 7.3.4.3. South America Foot Drop Treatment Devices Market Size in USD million (2021-2030)

8. Foot Drop Treatment Devices Market Company and Product Profiles

• 8.1. Ottobock
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Bioness Inc
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. AxioBionics
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Saebo, Inc.
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. OrthoPediatrics Corp.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Turbomed Orthotics
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Ossur
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Thrive Orthopedics
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Allard USA Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. NextStep Robotics
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Arthrex, Inc.
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Evolution Devices
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Narang Medical Limited
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. AliMed
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Cionic
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us